0001127602-20-030093.txt : 20201130 0001127602-20-030093.hdr.sgml : 20201130 20201130104730 ACCESSION NUMBER: 0001127602-20-030093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201125 FILED AS OF DATE: 20201130 DATE AS OF CHANGE: 20201130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bihl Anthony P III CENTRAL INDEX KEY: 0001432665 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 201356788 MAIL ADDRESS: STREET 1: 807 SMITH RIDGE ROAD CITY: NEW CANAAN STATE: CT ZIP: 06840 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-11-25 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001432665 Bihl Anthony P III 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 1 Common Stock 2020-11-25 4 P 0 5000 17.6531 A 10851 D Prices range from $17.5790 per share to $17.6700 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer. /s/ Bryan T. Baldasare, as Attorney-in-Fact for Anthony P. Bihl III 2020-11-30